Drug intelligence / Profile preview

inactivated staphylococcus albus

Development stage
Unknown
Lead developer
Shenhua Pharmaceutical
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

Inactivated staphylococcus albus is an oral bacterial preparation composed of killed *Staphylococcus albus* (now taxonomically classified as *Staphylococcus epidermidis*). Developed and manufactured by Shenhua Pharmaceutical, it is primarily utilized in China as a non-specific immunomodulator for the treatment of chronic bronchitis and recurrent respiratory tract infections. The preparation is designed to stimulate the host's immune system, particularly the non-specific immune response, thereby increasing resistance to bacterial pathogens in the respiratory tract. It is administered in the form of oral tablets and is considered an oral bacterial vaccine or lysate-like therapy.

Brand names
Bai Putao Qiu Jun Pian
Other names
Staphylococcus Albus TabletsStaphylococcus Epidermidis TabletsInactivated Staphylococcus Albus Preparation

Beyond the preview

Go deeper on inactivated staphylococcus albus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on inactivated staphylococcus albus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call